13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000884300
Total reported value
$127.2M
$127.2M
82 檔
22.5%
As reported in its official Q1 2025 Form 13F filing, Perkins Capital Management Inc's tracked investment portfolio stood at $127.2M with 82 total positions.
In Q1 2025, Perkins Capital Management Inc displayed an active expansion posture, initiating 50 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 8.53% | +0.58% | -1.16% | |
| 2 | NTRA | Natera Inc | Stock-Healthcare | 7.43% | +0.37% | -1.68% | |
| 3 | AXGN | Axogen Inc | Stock-Other | 4.95% | +0.13% | -2.94% | |
| 4 | MSFT | Microsoft CORP | Stock-Tech | 4.90% | -0.68% | -0.20% | |
| 5 | IDXX | Idexx Laboratories Inc | Stock-Healthcare | 4.30% | -1.09% | — | |
| 6 | ABT | Abbott Laboratories | Stock-Healthcare | 3.12% | -0.54% | — | |
| 7 | ELUT | Elutia Inc | Stock-Other | 3.03% | -0.44% | +32.13% | |
| 8 | LMAT | Lemaitre Vascular Inc | Stock-Other | 2.87% | -0.73% | -0.77% | |
| 9 | VCYT | Veracyte Inc | Stock-Other | 2.71% | +0.50% | -4.05% | |
| 10 | OOMA | Ooma Inc | Stock-Other | 2.64% | +0.21% | +0.40% | |
| 11 | INUVGBP | Inuvo Inc | Stock-Other | 2.63% | — | -0.96% | |
| 12 | AMD | Advanced Micro Devices | Stock-Tech | 2.25% | +3.39% | — | |
| 13 | UTE0 | Cantaloupe Inc | Stock-Other | 1.95% | — | -0.74% | |
| 14 | ATEC | Alphatec Holdings Inc | Stock-Other | 1.93% | -0.56% | -0.58% | |
| 15 | NEO | Neogenomics Inc | Stock-Healthcare | 1.80% | +0.34% | +0.34% | |
| 16 | ✓ | Mdxhealth SA | Stock-Other | 1.77% | -2.72% | +20.13% | |
| 17 | MGNI | Magnite Inc | Stock-Other | 1.75% | +0.14% | +0.90% | |
| 18 | XGN | Exagen Inc | Stock-Other | 1.60% | +0.01% | -0.18% | |
| 19 | USIO | Usio Inc | Stock-Other | 1.53% | +0.62% | — | |
| 20 | BLZE | Backblaze Inc-a | Stock-Other | 1.45% | +2.75% | +0.11% | |
| 21 | ABBV | Abbvie Inc | Stock-Healthcare | 1.38% | -0.04% | -1.24% | |
| 22 | VCEL | Vericel CORP | Stock-Other | 1.25% | -0.32% | EXIT | |
| 23 | GILD | Gilead Sciences Inc | Stock-Healthcare | 1.22% | -0.22% | -4.62% | |
| 24 | TELA | Tela Bio Inc | Stock-Other | 1.17% | -0.01% | +0.30% | |
| 25 | LFVN | Lifevantage CORP | Stock-Other | 1.16% | +0.06% | -0.53% | |
| 26 | APPS | Digital Turbine Inc | Stock-Other | 1.11% | — | — | |
| 27 | QUIK | Quicklogic CORP | Stock-Other | 1.09% | +1.35% | — | |
| 28 | PFE | Pfizer Inc | Stock-Healthcare | 1.09% | -0.30% | -1.80% | |
| 29 | AAPL | Apple Inc | Stock-Tech | 1.09% | -0.03% | — | |
| 30 | CYRX | Cryoport Inc | Stock-Other | 1.02% | +0.89% | -0.06% | |
| 31 | ATRC | Atricure Inc | Stock-Other | 1.02% | -0.31% | -1.48% | |
| 32 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.99% | -0.11% | — | |
| 33 | BKSY | Blacksky Technology Inc | Stock-Other | 0.99% | -0.05% | — | |
| 34 | PSNL | Personalis Inc | Stock-Other | 0.95% | +1.09% | — | |
| 35 | T | At&t Inc | Stock-Comm Services | 0.94% | -0.17% | -3.51% | |
| 36 | CDXS | Codexis Inc | Stock-Other | 0.90% | +0.13% | +69.26% | |
| 37 | CIEN | Ciena CORP | Stock-Tech | 0.90% | -0.80% | — | |
| 38 | CXDO | Crexendo Inc | Stock-Other | 0.88% | +0.12% | +241.20% | |
| 39 | VFF | Village Farms International | Stock-Other | 0.84% | — | +21.13% | |
| 40 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.82% | -0.09% | -3.74% | |
| 41 | SKYT | Skywater Technology Inc | Stock-Other | 0.78% | -0.35% | -0.48% | |
| 42 | GIS | General Mills Inc | Stock-Consumer Staples | 0.72% | +0.03% | -33.91% | |
| 43 | COP | Conocophillips | Stock-Energy | 0.72% | -0.22% | -5.11% | |
| 44 | CSTL | Castle Biosciences Inc | Stock-Other | 0.72% | -0.05% | -0.59% | |
| 45 | FAST | Fastenal Co | Stock-Industrials | 0.70% | -0.05% | — | |
| 46 | ✓ | Biodesix Inc | Stock-Other | 0.70% | — | -0.05% | |
| 47 | BFLY | Butterfly Network Inc | Stock-Other | 0.66% | +2.23% | — | |
| 48 | ANIP | Ani Pharmaceuticals Inc | Stock-Other | 0.60% | -0.57% | EXIT | |
| 49 | TGT | Target CORP | Stock-Consumer Disc | 0.59% | -0.07% | — | |
| 50 | HAIN | Hain Celestial Group Inc | Stock-Other | 0.59% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | — | NEW | New buy |
| 2 | NTRA | Natera Inc | — | NEW | New buy |
| 3 | AXGN | Axogen Inc | — | NEW | New buy |
| 4 | MSFT | Microsoft CORP | — | NEW | New buy |
| 5 | IDXX | Idexx Laboratories Inc | — | NEW | New buy |
| 6 | ABT | Abbott Laboratories | — | NEW | New buy |
| 7 | ELUT | Elutia Inc | — | NEW | New buy |
| 8 | LMAT | Lemaitre Vascular Inc | — | NEW | New buy |
| 9 | VCYT | Veracyte Inc | — | NEW | New buy |
| 10 | OOMA | Ooma Inc | — | NEW | New buy |
| 11 | INUVGBP | Inuvo Inc | — | NEW | New buy |
| 12 | AMD | Advanced Micro Devices | — | NEW | New buy |
| 13 | UTE0 | Cantaloupe Inc | — | NEW | New buy |
| 14 | ATEC | Alphatec Holdings Inc | — | NEW | New buy |
| 15 | NEO | Neogenomics Inc | — | NEW | New buy |
| 16 | ✓ | Mdxhealth SA | — | NEW | New buy |
| 17 | MGNI | Magnite Inc | — | NEW | New buy |
| 18 | XGN | Exagen Inc | — | NEW | New buy |
| 19 | USIO | Usio Inc | — | NEW | New buy |
| 20 | BLZE | Backblaze Inc-a | — | NEW | New buy |
| 21 | ABBV | Abbvie Inc | — | NEW | New buy |
| 22 | VCEL | Vericel CORP | — | NEW | New buy |
| 23 | GILD | Gilead Sciences Inc | — | NEW | New buy |
| 24 | TELA | Tela Bio Inc | — | NEW | New buy |
| 25 | LFVN | Lifevantage CORP | — | NEW | New buy |
| 26 | APPS | Digital Turbine Inc | — | NEW | New buy |
| 27 | QUIK | Quicklogic CORP | — | NEW | New buy |
| 28 | PFE | Pfizer Inc | — | NEW | New buy |
| 29 | AAPL | Apple Inc | — | NEW | New buy |
| 30 | CYRX | Cryoport Inc | — | NEW | New buy |
| 31 | ATRC | Atricure Inc | — | NEW | New buy |
| 32 | MRK | Merck & Co. Inc. | — | NEW | New buy |
| 33 | BKSY | Blacksky Technology Inc | — | NEW | New buy |
| 34 | PSNL | Personalis Inc | — | NEW | New buy |
| 35 | T | At&t Inc | — | NEW | New buy |
| 36 | CDXS | Codexis Inc | — | NEW | New buy |
| 37 | CIEN | Ciena CORP | — | NEW | New buy |
| 38 | CXDO | Crexendo Inc | — | NEW | New buy |
| 39 | VFF | Village Farms International | — | NEW | New buy |
| 40 | BMY | Bristol-myers Squibb Co | — | NEW | New buy |
| 41 | SKYT | Skywater Technology Inc | — | NEW | New buy |
| 42 | GIS | General Mills Inc | — | NEW | New buy |
| 43 | COP | Conocophillips | — | NEW | New buy |
| 44 | CSTL | Castle Biosciences Inc | — | NEW | New buy |
| 45 | FAST | Fastenal Co | — | NEW | New buy |
| 46 | ✓ | Biodesix Inc | — | NEW | New buy |
| 47 | BFLY | Butterfly Network Inc | — | NEW | New buy |
| 48 | ANIP | Ani Pharmaceuticals Inc | — | NEW | New buy |
| 49 | TGT | Target CORP | — | NEW | New buy |
| 50 | HAIN | Hain Celestial Group Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Perkins Capital Management Inc reported a total U.S. public equity portfolio value of $127.2M across 82 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including LLY, NTRA, AXGN) accounted for 22.5% of total reported equity market value during Q1 2025.
Top New Position Initiated
LLY
市值: $8.1M
During Q1 2025, Perkins Capital Management Inc's top holdings by market value included LLY (8.5%)、NTRA (7.4%)、AXGN (5.0%). The largest single position, LLY, represented 8.5% of total portfolio value.
In Q1 2025, Perkins Capital Management Inc made 50 total portfolio adjustments, initiating 50 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.